These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30800009)

  • 1. Patient attitudes toward novel glaucoma drug delivery approaches.
    Wang BB; Lin MM; Nguyen T; Turalba AV
    Digit J Ophthalmol; 2018; 24(2):16-23. PubMed ID: 30800009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Survey on the Preference of Sustained Glaucoma Drug Delivery Systems by Singaporean Chinese Patients: A Comparison Between Subconjunctival, Intracameral, and Punctal Plug Routes.
    Chan HH; Wong TT; Lamoureux E; Perera S
    J Glaucoma; 2015 Sep; 24(7):485-92. PubMed ID: 25580892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Acceptance of Sustained Glaucoma Treatment Strategies.
    Varadaraj V; Kahook MY; Ramulu PY; Pitha IF
    J Glaucoma; 2018 Apr; 27(4):328-335. PubMed ID: 29462013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Glaucoma Drug Delivery Devices.
    Lin MM; Ciolino JB; Pasquale LR
    Int Ophthalmol Clin; 2017; 57(4):57-71. PubMed ID: 28885247
    [No Abstract]   [Full Text] [Related]  

  • 5. Acceptance, attitudes, and beliefs of Singaporean Chinese toward an ocular implant for glaucoma drug delivery.
    Foo RC; Lamoureux EL; Wong RC; Ho SW; Chiang PP; Rees G; Aung T; Wong TT
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8240-5. PubMed ID: 23188725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Survey on Patients' Opinions of Alternative Drug Delivery Systems for the Treatment of Glaucoma in South-South Nigeria.
    Echieh CI; Mercieca K; Eze UA; Weber C; Akinyemi A; Ibanga AA; Echieh CP
    Middle East Afr J Ophthalmol; 2022; 29(4):220-225. PubMed ID: 38162567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular drug delivery systems: glaucoma patient perceptions from a German university hospital eye clinic.
    Weber C; Quintin P; Holz FG; Fea A; Mercieca K
    Graefes Arch Clin Exp Ophthalmol; 2024 Feb; 262(2):545-556. PubMed ID: 37776338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
    Rees G; Leong O; Crowston JG; Lamoureux EL
    Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
    J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained drug delivery for glaucoma: current data and future trends.
    Aref AA
    Curr Opin Ophthalmol; 2017 Mar; 28(2):169-174. PubMed ID: 27764023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication.
    Salyani A; Birt C
    Can J Ophthalmol; 2005 Apr; 40(2):170-4. PubMed ID: 16049530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirror-hat device as a drop delivery aid: a pilot study.
    Strungaru MH; Peck J; Compeau EC; Trope GE; Buys YM
    Can J Ophthalmol; 2014 Aug; 49(4):333-8. PubMed ID: 25103649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate.
    Sah AK; Suresh PK
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):448-459. PubMed ID: 27002850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery by contact lens in spontaneously glaucomatous dogs.
    Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
    Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma.
    Kompella UB; Hartman RR; Patil MA
    Prog Retin Eye Res; 2021 May; 82():100901. PubMed ID: 32891866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of eye drop instillation technique in glaucoma patients.
    Gomes BF; Paredes AF; Madeira N; Moraes HV; Santhiago MR
    Arq Bras Oftalmol; 2017; 80(4):238-241. PubMed ID: 28954024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO).
    Vandenbroeck S; De Geest S; Dobbels F; Fieuws S; Stalmans I; Zeyen T
    J Glaucoma; 2011 Sep; 20(7):414-21. PubMed ID: 21048510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
    O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
    Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of ocular surface diseases in the management of glaucoma].
    Van Went C; Brasnu E; Hamard P; Baudouin C; Labbé A
    J Fr Ophtalmol; 2011 Apr; 34(4):230-7. PubMed ID: 21439676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.